Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Fu, Yujie ^a,b   Chang, Hui ^a   Peng, Xiaoli ^a,c   Bai, Qian ^a   Yi, Long ^a   Zhou, Yong ^a   Zhu, Jundong ^a   Mi, Mantian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

^c CHENGDU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; BETA CATENIN; GREEN FLUORESCENT PROTEIN; PROTEIN; PROTEIN ATG 7; PROTEIN LC3 II; RESVERATROL; UNCLASSIFIED DRUG; WNT PROTEIN; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER INHIBITION; CANCER STEM CELL; CELL COUNT; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; BREAST TUMOR; DRUG EFFECTS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AUTOPHAGY; BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STILBENES; WNT PROTEINS;

EID: 84904903972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102535     Document Type: Article

References (39)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 7: 3983-3988. (Pubitemid 36418143)
2. Hui C, Yujie F, Lijia Y (2012) MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea - induced breast carcinogenesis. Breast Cancer Res. 3:R80.
3. Lobo NA, Shimono Y, Qian D (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol. 23: 675-699.
4. Ponti D, Costa A, Zaffaroni N (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 13: 5506-5511 (Pubitemid 40911148)
5. Fillmore C, Kuperwasser C (2007) Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Res. 3: 303.
6. Preffer F, Dombkowski D (2009) Advances in complex multiparameter flow cytometry technology: Applications in stem cell research. Cytometry B Clin Cytom. 76(5):295-314.
7. Cufí S, Vazquez-Martin A, Oliveras-Ferraros C (2011) Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cell Cycle. 10(22):3871-3885.
8. de Beça FF, Caetano P, Gerhard R (2013) Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol. 3: 187-191
9. Charafe-Jauffret E, Ginestier C, Iovino F (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 1: 45-55.
10. Charafe-Jauffret E, Ginestier C, Iovino F (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69: 1302-1313
11. Hu Y, Fu L (2012) Targeting cancer stem cells: a new therapy to cure cancer patients. Am J Cancer Res. 3:340-356.
12. Chuthapisith S, Eremin J, El-Sheemey M (2010) Breast cancer chemoresistance: Emerging importance of cancer stem cells. Surg Oncol 1: 27-32.
13. Nicolini A, Ferrari P, Fini M (2011) Stem cells: their role in breast cancer development and resistance to treatment. Curr Pharm Biotechnol. 2: 196-205.
14. Kaminski BM, Steinhilber D, Stein JM (2012) Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies. Curr Pharm Biotechnol. 1: 137-146.
15. Li Z, Li J, Mo B (2008) Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol. 5: 401-409.
16. Lin Y, Shi R, Wang X (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 7: 634-646.
17. Harikumar KB, Kunnumakkara AB, Sethi G (2010) Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2: 257-268.
18. Alayev A, Sun Y, Snyder RB (2014) Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle. 13(3):371-382.
19. Vergara D, Simeone P, Toraldo D (2012) Resceratrol downregulates Akt/GSK and ERK signaling pathways in OVCAR-3 ovarian cancer cells. Biosyst. 4:1078-1087.
20. Chen Q, Ganapathy S, Singh KP (2010) Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells. PloS One.12:e15288.
21. Pandey PR, Okuda H, Watabe M (2011) Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 130(2): 387-398.
22. Oi N, Jeong CH, Nadas J (2010) Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4hydrolase. Cancer Res. 23: 9755-9764.
23. Patel KR, Brown VA, Jones DJ (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 19: 7392-7399.
24. Ge J, Liu Y, Li Q (2013) Resveratrol Induces Apoptosis and Autophagy in T-cell Acute Lymphoblastic Leukemia Cells by Inhibiting Akt/mTOR and Activating p38-MAPK. Biomed Environ Sci. 11: 902-911.
25. Fukui M, Yamabe N, Kang KS (2010) Growth-Stimulatory Effect of Resveratrol in Human Cancer Cells. Mol Carcinog. 8: 750-759.
26. Patel VB, Misra S, Patel BB (2010) Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer. 7: 958-967.
27. Li Y, Zhang T, Korkaya H (2010) Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 9: 2580-2590.
28. Günther S, Ruhe C, Derikito MG (2007) Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. Cancer Lett. 250(1):25-35. (Pubitemid 46483841)
29. Sui X, Chen R, Wang Z (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis.4:e838.
30. Amaravadi RK, Lippincott-Schwartz J, Yin XM (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 4: 654-666.
31. Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 9(12):1004-1010.
32. Kimmelman AC (2011) The dynamic nature of autophagy in cancer. Genes Dev. 19: 1999-2010
33. Mai TT, Moon J, Song Y (2012) Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells, Cancer Lett. 2: 144-153.
34. Patel VB, Misra S, Patel BB (2010) Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer. 7: 958-967.
35. Filippi-Chiela EC, Villodre ES, Zamin LL (2011) Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One. 6(6):e20849
36. Lindeman GJ, Visvader JE (2010) Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia Pac J Clin Oncol. 2: 89-97.
37. Kang R, Zeh HJ, Lotze MT (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 4: 571-580.
38. Teiten MH, Gasscht F, Cronauer M (2011) Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol. 38(3):603-611.
39. Hope C, Planutis K, Planutiene M (2008) Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res. 52: S52-S61.